VYNE Therapeutics Inc – Jahresabschlüsse (NASDAQ:VYNE) | MetaTrader

Vollständige Grafik anzeigen

Nachrichten

VYNE Therapeutics und Yarrow Bioscience fusionieren in 200-Millionen-Dollar-Transaktion

VYNE Therapeutics to merge with Yarrow Bioscience in $200 million deal

VYNE Therapeutics Inc. (VYNE) Yarrow Bioscience, Inc. - M&A Call Prepared Remarks Transcript

Fusion mit Yarrow Bioscience beflügelt Aktie von Vyne Therapeutics

Vyne Therapeutics stock soars after merger with Yarrow Bioscience

VYNE and Yarrow Bioscience to merge in all-stock transaction

Crude Oil Rises Over 1%; General Mills Earnings Top Views - DBV Technologies (NASDAQ:DBVT), General Mills (NYSE:GIS)

Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Aditxt (NASDAQ:ADTX), Agape ATP (NASDAQ:ATPC)

VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates

VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates

Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates